Details of the Drug Combinations

General Information of This Drug (ID: DM4OYXE)

Drug Name
LIAROZOLE   DM4OYXE
Synonyms
Liarozole; Liazal; 115575-11-6; R-75251; LIAROZOLE FUMARATE; Liarozole [INN:BAN]; Liarozolum [INN-Latin]; Liarozol [INN-Spanish]; R 75251; R-61405; R085246; R 61405; R-085246; R 085246; 6-((3-chlorophenyl)(1H-imidazol-1-yl)methyl)-1H-benzo[d]imidazole; UNII-17NYD2210B; CHEMBL389433; UNII-090Y06W08H; 17NYD2210B; 090Y06W08H; Liarozolum; Liarozol; 1H-Benzimidazole, 5-((3-chlorophenyl)-1H-imidazol-1-ylmethyl)-; NCGC00181034-01; Liarozole, (-)-; Liarozole, (+)-; AC1L1TNN; AC1Q3M3B; SCHEMBL18597; GTPL5210; SCHEMBL15944205; DTXSID9048277
Indication
Disease Entry ICD 11 Status REF
Dermatological disease DA24.Y Phase 2/3 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

311 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
ABIRATERONE + LIAROZOLE DCYM99B ABIRATERONE Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
ABIRATERONE + LIAROZOLE DC349BI ABIRATERONE Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + LIAROZOLE DC99LKP ABIRATERONE Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
ABIRATERONE + LIAROZOLE DCIIVLD ABIRATERONE Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Amonafide + LIAROZOLE DCWIA14 Amonafide Adenocarcinoma (Cell Line: SW-620) [2]
Amonafide + LIAROZOLE DC1DSBV Amonafide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Amonafide + LIAROZOLE DCM61TA Amonafide Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Amonafide + LIAROZOLE DCSX2Q5 Amonafide Glioma (Cell Line: SF-268) [2]
Amonafide + LIAROZOLE DCSSTEQ Amonafide Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
Amonafide + LIAROZOLE DCDKV2X Amonafide Colon adenocarcinoma (Cell Line: COLO 205) [4]
Anastrozole + LIAROZOLE DCMUE8J Anastrozole Adenocarcinoma (Cell Line: HCT-15) [2]
Anastrozole + LIAROZOLE DCN2T05 Anastrozole Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Anastrozole + LIAROZOLE DC1ZZEK Anastrozole Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Anastrozole + LIAROZOLE DCWVWC2 Anastrozole Clear cell renal cell carcinoma (Cell Line: A498) [2]
Anastrozole + LIAROZOLE DCDM54M Anastrozole Cutaneous melanoma (Cell Line: SK-MEL-28) [2]
Anastrozole + LIAROZOLE DC7OTZ9 Anastrozole High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [2]
Anastrozole + LIAROZOLE DCURS8Y Anastrozole Lung adenocarcinoma (Cell Line: NCI-H522) [2]
Anastrozole + LIAROZOLE DCZK7ME Anastrozole Malignant melanoma (Cell Line: LOX IMVI) [2]
Anastrozole + LIAROZOLE DC3ZUUG Anastrozole Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
Anastrozole + LIAROZOLE DCG0XFA Anastrozole Papillary renal cell carcinoma (Cell Line: ACHN) [2]
Anastrozole + LIAROZOLE DCE063V Anastrozole Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Anastrozole + LIAROZOLE DCL5W1C Anastrozole Prostate carcinoma (Cell Line: PC-3) [2]
Anastrozole + LIAROZOLE DCNXHSD Anastrozole Carcinoma (Cell Line: RXF 393) [4]
Arfolitixorin + LIAROZOLE DC62O44 Arfolitixorin Glioma (Cell Line: SF-268) [2]
Arfolitixorin + LIAROZOLE DCOEAZ9 Arfolitixorin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
BIO-300 + LIAROZOLE DCSZI8V BIO-300 Astrocytoma (Cell Line: SNB-19) [2]
BIO-300 + LIAROZOLE DCY6SA2 BIO-300 Glioma (Cell Line: SF-268) [2]
BIO-300 + LIAROZOLE DC9462R BIO-300 Colon adenocarcinoma (Cell Line: COLO 205) [4]
BIO-300 + LIAROZOLE DCKRB3O BIO-300 Adenocarcinoma (Cell Line: HCT116) [3]
BIO-300 + LIAROZOLE DC7Q019 BIO-300 Adenocarcinoma (Cell Line: SW-620) [3]
BIO-300 + LIAROZOLE DCH0KN3 BIO-300 Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Bleomycin + LIAROZOLE DCJSLJ1 Bleomycin Papillary renal cell carcinoma (Cell Line: ACHN) [2]
Bleomycin + LIAROZOLE DCBZMB6 Bleomycin Colon adenocarcinoma (Cell Line: COLO 205) [4]
Cabazitaxel + LIAROZOLE DC5M76W Cabazitaxel Astrocytoma (Cell Line: SNB-19) [2]
Cabazitaxel + LIAROZOLE DCSTVG0 Cabazitaxel Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Cabazitaxel + LIAROZOLE DC10VW1 Cabazitaxel Glioma (Cell Line: SF-295) [2]
Cabazitaxel + LIAROZOLE DCRUFQA Cabazitaxel Glioma (Cell Line: SF-539) [2]
Crizotinib + LIAROZOLE DCJT59J Crizotinib Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Dacarbazine + LIAROZOLE DCLHTKO Dacarbazine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
Dactinomycin + LIAROZOLE DCDLV9P Dactinomycin Carcinoma (Cell Line: MCF7) [4]
Dactinomycin + LIAROZOLE DCFFQHL Dactinomycin Adenocarcinoma (Cell Line: OVCAR3) [3]
Dactinomycin + LIAROZOLE DCUCS15 Dactinomycin Adenocarcinoma (Cell Line: A549) [3]
Dactinomycin + LIAROZOLE DC0JV75 Dactinomycin Adenocarcinoma (Cell Line: HT29) [3]
Dactinomycin + LIAROZOLE DC5I67Y Dactinomycin Adenocarcinoma (Cell Line: HCT116) [3]
Dactinomycin + LIAROZOLE DCJMZRJ Dactinomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Dactinomycin + LIAROZOLE DC6RRAZ Dactinomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Dactinomycin + LIAROZOLE DCCSUTU Dactinomycin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Dactinomycin + LIAROZOLE DCRKIJX Dactinomycin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Dactinomycin + LIAROZOLE DCHRG4R Dactinomycin Prostate carcinoma (Cell Line: PC-3) [3]
Dantrolene + LIAROZOLE DCBOHYQ Dantrolene Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Dexrazoxane + LIAROZOLE DCBDUYW Dexrazoxane Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Dexrazoxane + LIAROZOLE DC9MH7O Dexrazoxane Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Dexrazoxane + LIAROZOLE DCDGH62 Dexrazoxane Colon adenocarcinoma (Cell Line: COLO 205) [4]
Dexrazoxane + LIAROZOLE DCPT2NW Dexrazoxane Colon carcinoma (Cell Line: KM12) [4]
Epirubicin + LIAROZOLE DCJUC5E Epirubicin Carcinoma (Cell Line: RXF 393) [4]
Epirubicin + LIAROZOLE DCPPMLQ Epirubicin Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Gefitinib + LIAROZOLE DC6GU4B Gefitinib Anaplastic large cell lymphoma (Cell Line: SR) [2]
Gefitinib + LIAROZOLE DCFA9HE Gefitinib Astrocytoma (Cell Line: SNB-19) [2]
Gefitinib + LIAROZOLE DCU3BCP Gefitinib Clear cell renal cell carcinoma (Cell Line: A498) [2]
Gefitinib + LIAROZOLE DCM0S2P Gefitinib Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
Gefitinib + LIAROZOLE DC5EUMN Gefitinib Glioma (Cell Line: SF-268) [2]
Gefitinib + LIAROZOLE DC4VJLX Gefitinib Melanoma (Cell Line: MALME-3M) [2]
Gefitinib + LIAROZOLE DCTN1MI Gefitinib Papillary renal cell carcinoma (Cell Line: ACHN) [2]
Gefitinib + LIAROZOLE DCU90U8 Gefitinib Colon carcinoma (Cell Line: KM12) [4]
Indazole derivative 5 + LIAROZOLE DCMJUPQ Indazole derivative 5 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Indazole derivative 5 + LIAROZOLE DC4G1PH Indazole derivative 5 Carcinoma (Cell Line: RXF 393) [4]
JNK-IN-8 + LIAROZOLE DCMR3PF JNK-IN-8 Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Lacosamide + LIAROZOLE DC7DDEM Lacosamide Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Lenalidomide + LIAROZOLE DCKZHXU Lenalidomide Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Lenalidomide + LIAROZOLE DCU4XEX Lenalidomide Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Lenalidomide + LIAROZOLE DCMQ8YU Lenalidomide Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Letrozole + LIAROZOLE DCWX2AR Letrozole Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Letrozole + LIAROZOLE DCS0JRC Letrozole Clear cell renal cell carcinoma (Cell Line: A498) [2]
Letrozole + LIAROZOLE DCMQURF Letrozole High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [2]
Letrozole + LIAROZOLE DCQT1Y4 Letrozole Lung adenocarcinoma (Cell Line: HOP-62) [2]
Letrozole + LIAROZOLE DCEFSWK Letrozole Papillary renal cell carcinoma (Cell Line: ACHN) [2]
LIAROZOLE + Ribavirin-TP DCMKWWO Ribavirin-TP Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LIAROZOLE + Pentostatin DCBV33M Pentostatin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
LIAROZOLE + Pentostatin DC15S25 Pentostatin Chronic myelogenous leukemia (Cell Line: K-562) [2]
LIAROZOLE + Pentostatin DCYCVQP Pentostatin Renal cell carcinoma (Cell Line: SN12C) [2]
LIAROZOLE + Fulvestrant DCLETOC Fulvestrant Glioma (Cell Line: SF-268) [2]
LIAROZOLE + Diethylcarbamazine DC6SIQO Diethylcarbamazine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LIAROZOLE + Ixabepilone DCZ025P Ixabepilone Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
LIAROZOLE + Ixabepilone DCHAVZB Ixabepilone Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
LIAROZOLE + Dactinomycin DC6J96C Dactinomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
LIAROZOLE + Dactinomycin DC1LN9L Dactinomycin Anaplastic large cell lymphoma (Cell Line: SR) [2]
LIAROZOLE + Dactinomycin DCNA9SA Dactinomycin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LIAROZOLE + Lapatinib DC6RTAY Lapatinib Astrocytoma (Cell Line: SNB-19) [2]
LIAROZOLE + PMID28460551-Compound-2 DCY6W76 PMID28460551-Compound-2 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
LIAROZOLE + PMID28460551-Compound-2 DC3WYSS PMID28460551-Compound-2 Anaplastic large cell lymphoma (Cell Line: SR) [2]
LIAROZOLE + PMID28460551-Compound-2 DCLR8YA PMID28460551-Compound-2 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
LIAROZOLE + PMID28460551-Compound-2 DC1FUV4 PMID28460551-Compound-2 Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LIAROZOLE + PMID28460551-Compound-2 DC4JHLH PMID28460551-Compound-2 Papillary renal cell carcinoma (Cell Line: ACHN) [2]
LIAROZOLE + Arsenic trioxide DCE7E1L Arsenic trioxide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
LIAROZOLE + Arsenic trioxide DCHCHIZ Arsenic trioxide Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
LIAROZOLE + Arsenic trioxide DC5EBXZ Arsenic trioxide Astrocytoma (Cell Line: U251) [2]
LIAROZOLE + Plicamycin DCJ8B5F Plicamycin Anaplastic large cell lymphoma (Cell Line: SR) [2]
LIAROZOLE + Plicamycin DCM1H09 Plicamycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
LIAROZOLE + Triapine DC6E069 Triapine Anaplastic large cell lymphoma (Cell Line: SR) [2]
LIAROZOLE + 10-hydroxycamptothecin DCAS1HV 10-hydroxycamptothecin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
LIAROZOLE + 10-hydroxycamptothecin DCOBU1V 10-hydroxycamptothecin Anaplastic large cell lymphoma (Cell Line: SR) [2]
LIAROZOLE + 10-hydroxycamptothecin DCS0S2U 10-hydroxycamptothecin Astrocytoma (Cell Line: SNB-19) [2]
LIAROZOLE + 10-hydroxycamptothecin DCB6QVS 10-hydroxycamptothecin Glioma (Cell Line: SF-539) [2]
LIAROZOLE + 10-hydroxycamptothecin DCYV29T 10-hydroxycamptothecin Papillary renal cell carcinoma (Cell Line: ACHN) [2]
LIAROZOLE + Topetecan DCFV1IF Topetecan Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
LIAROZOLE + Topetecan DCCK7E2 Topetecan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
LIAROZOLE + Topetecan DCFXXND Topetecan Anaplastic large cell lymphoma (Cell Line: SR) [2]
LIAROZOLE + Topetecan DCPKCA5 Topetecan Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
LIAROZOLE + Metyrosine DCXG3HU Metyrosine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LIAROZOLE + Terameprocol DCVFB6N Terameprocol Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LIAROZOLE + Docetaxel DC6D0LE Docetaxel Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
LIAROZOLE + Docetaxel DCRXE6L Docetaxel Chronic myelogenous leukemia (Cell Line: K-562) [2]
LIAROZOLE + Docetaxel DCPDVAY Docetaxel Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
LIAROZOLE + Docetaxel DCERS0H Docetaxel Clear cell renal cell carcinoma (Cell Line: A498) [2]
LIAROZOLE + Docetaxel DC8ZVET Docetaxel Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
LIAROZOLE + Raloxifene DCGTIC1 Raloxifene Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
LIAROZOLE + Raloxifene DCZRKZO Raloxifene Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
LIAROZOLE + JZL195 DCKB290 JZL195 Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LIAROZOLE + Bendamustine hydrochloride DCZHVIO Bendamustine hydrochloride Anaplastic large cell lymphoma (Cell Line: SR) [2]
LIAROZOLE + Sirolimus DCZ4JHV Sirolimus Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
LIAROZOLE + Sirolimus DCRC9UZ Sirolimus Astrocytoma (Cell Line: SNB-19) [2]
LIAROZOLE + Sirolimus DCJKKG0 Sirolimus Glioma (Cell Line: SF-295) [2]
LIAROZOLE + Mitomycin DC9BNWV Mitomycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
LIAROZOLE + Mitomycin DCC94WR Mitomycin Glioma (Cell Line: SF-539) [2]
LIAROZOLE + Vincristine DCKTQE7 Vincristine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
LIAROZOLE + BIO-300 DCDREQ7 BIO-300 Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LIAROZOLE + Niclosamide DCGSA5P Niclosamide Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LIAROZOLE + Tiagabine DC974GV Tiagabine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LIAROZOLE + Diazoxide DC9GLDL Diazoxide Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LIAROZOLE + Imatinib DC04XO2 Imatinib Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LIAROZOLE + Bleomycin DCQWJ9L Bleomycin Chronic myelogenous leukemia (Cell Line: K-562) [2]
LIAROZOLE + Pramipexole DC5HA4O Pramipexole Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LIAROZOLE + Bortezomib DCKOMKB Bortezomib Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LIAROZOLE + Methylene blue DC9VGLV Methylene blue Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LIAROZOLE + Leflunomide DCGKL3Y Leflunomide Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LIAROZOLE + Cisplatin DC6R17R Cisplatin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
LIAROZOLE + Cisplatin DCUYQVU Cisplatin Anaplastic large cell lymphoma (Cell Line: SR) [2]
LIAROZOLE + Chlorambucil DC2GQ2D Chlorambucil Anaplastic large cell lymphoma (Cell Line: SR) [2]
LIAROZOLE + Chlorambucil DCCPOD0 Chlorambucil Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
LIAROZOLE + Brincidofovir DCU5Y6L Brincidofovir Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LIAROZOLE + ER819762 DCKKIB9 ER819762 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
LIAROZOLE + ER819762 DCSO0X5 ER819762 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
LIAROZOLE + ER819762 DCLSRPL ER819762 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
LIAROZOLE + Romidepsin DCHWXQ8 Romidepsin Glioma (Cell Line: SF-539) [2]
LIAROZOLE + Vinflunine DCMY449 Vinflunine Papillary renal cell carcinoma (Cell Line: ACHN) [2]
LIAROZOLE + Taxol DCRLXD7 Taxol Glioma (Cell Line: SF-268) [2]
LIAROZOLE + Fludarabine DCGH005 Fludarabine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
LIAROZOLE + Fludarabine DC2BRCX Fludarabine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
LIAROZOLE + Fludarabine DCKCXUL Fludarabine Astrocytoma (Cell Line: U251) [2]
LIAROZOLE + Fludarabine DCTHSYG Fludarabine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
LIAROZOLE + Fludarabine DC748U6 Fludarabine Chronic myelogenous leukemia (Cell Line: K-562) [2]
LIAROZOLE + Fludarabine DCKO4WZ Fludarabine Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
LIAROZOLE + FORMESTANE DCJB3ZY FORMESTANE Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
LIAROZOLE + FORMESTANE DCV9LIH FORMESTANE Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
LIAROZOLE + Aminolevulinic Acid Hydrochloride DCJI90F Aminolevulinic Acid Hydrochloride Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
LIAROZOLE + Aminolevulinic Acid Hydrochloride DC1YS76 Aminolevulinic Acid Hydrochloride Anaplastic large cell lymphoma (Cell Line: SR) [2]
LIAROZOLE + Aminolevulinic Acid Hydrochloride DCFQDMA Aminolevulinic Acid Hydrochloride Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
LIAROZOLE + Aminolevulinic Acid Hydrochloride DCOODEK Aminolevulinic Acid Hydrochloride Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
LIAROZOLE + Estramustine DC053JV Estramustine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
LIAROZOLE + Estramustine DCBU065 Estramustine Anaplastic large cell lymphoma (Cell Line: SR) [2]
LIAROZOLE + Estramustine DCRUKQ1 Estramustine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LIAROZOLE + Digitoxin DCA0KGO Digitoxin Anaplastic large cell lymphoma (Cell Line: SR) [2]
LIAROZOLE + Lithium Citrate DCY8K07 Lithium Citrate Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LIAROZOLE + Cerivastatin DC6Q569 Cerivastatin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LIAROZOLE + Busulfan DC9ZNZ4 Busulfan Anaplastic large cell lymphoma (Cell Line: SR) [2]
LIAROZOLE + Busulfan DC9COTM Busulfan Astrocytoma (Cell Line: U251) [2]
LIAROZOLE + Dasatinib DCEPBOO Dasatinib Glioma (Cell Line: SF-268) [2]
LIAROZOLE + Cytarabine DCCBWOG Cytarabine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LIAROZOLE + Pentostatin DC3DPOZ Pentostatin Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
LIAROZOLE + Pentostatin DC14P0Q Pentostatin Colon carcinoma (Cell Line: KM12) [4]
LIAROZOLE + Pentostatin DCBX66D Pentostatin Invasive ductal carcinoma (Cell Line: BT-549) [4]
LIAROZOLE + Hepzato DCWIKXW Hepzato Carcinoma (Cell Line: RXF 393) [4]
LIAROZOLE + PMID28460551-Compound-2 DC0UB4M PMID28460551-Compound-2 Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
LIAROZOLE + PMID28460551-Compound-2 DC542L0 PMID28460551-Compound-2 Carcinoma (Cell Line: RXF 393) [4]
LIAROZOLE + Isoniazid DCDEMIW Isoniazid Carcinoma (Cell Line: RXF 393) [4]
LIAROZOLE + Nilotinib DCD5W55 Nilotinib Carcinoma (Cell Line: RXF 393) [4]
LIAROZOLE + SCH 727965 DCQE6YY SCH 727965 Carcinoma (Cell Line: MCF7) [4]
LIAROZOLE + SCH 727965 DC7MZHH SCH 727965 Invasive ductal carcinoma (Cell Line: HS 578T) [4]
LIAROZOLE + Sirolimus DCHLSC9 Sirolimus Colon adenocarcinoma (Cell Line: COLO 205) [4]
LIAROZOLE + Sirolimus DCFVQYW Sirolimus Invasive ductal carcinoma (Cell Line: T-47D) [4]
LIAROZOLE + Chlorambucil DCEWQIX Chlorambucil Colon adenocarcinoma (Cell Line: COLO 205) [4]
LIAROZOLE + Chlorambucil DCLCOAG Chlorambucil Invasive ductal carcinoma (Cell Line: T-47D) [4]
LIAROZOLE + ER819762 DCEU140 ER819762 Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
LIAROZOLE + ER819762 DC23DSP ER819762 Invasive ductal carcinoma (Cell Line: HS 578T) [4]
LIAROZOLE + Taxol DCZP0WZ Taxol Invasive ductal carcinoma (Cell Line: BT-549) [4]
LIAROZOLE + Taxol DCN40PB Taxol Invasive ductal carcinoma (Cell Line: HS 578T) [4]
LIAROZOLE + Pentostatin DCQS4H1 Pentostatin Adenocarcinoma (Cell Line: A549) [3]
LIAROZOLE + Pentostatin DCXHG8X Pentostatin Adenocarcinoma (Cell Line: HCT116) [3]
LIAROZOLE + Pentostatin DCO61GR Pentostatin Lung adenocarcinoma (Cell Line: HOP-62) [3]
LIAROZOLE + Pentostatin DC8F2FW Pentostatin Lung adenocarcinoma (Cell Line: NCI-H522) [3]
LIAROZOLE + Fulvestrant DCSMMG2 Fulvestrant Melanoma (Cell Line: UACC-257) [3]
LIAROZOLE + Hepzato DC2GVVK Hepzato Adenocarcinoma (Cell Line: OVCAR3) [3]
LIAROZOLE + Hepzato DCPOAYS Hepzato Adenocarcinoma (Cell Line: HT29) [3]
LIAROZOLE + Ixabepilone DC8S7BW Ixabepilone Lung adenocarcinoma (Cell Line: HOP-62) [3]
LIAROZOLE + PMID28460551-Compound-2 DCAID17 PMID28460551-Compound-2 Adenocarcinoma (Cell Line: DU-145) [3]
LIAROZOLE + PMID28460551-Compound-2 DCT3FEA PMID28460551-Compound-2 Large cell lung carcinoma (Cell Line: NCI-H460) [3]
LIAROZOLE + PMID28460551-Compound-2 DCA39DE PMID28460551-Compound-2 Malignant melanoma (Cell Line: UACC62) [3]
LIAROZOLE + PMID28460551-Compound-2 DCLT2SY PMID28460551-Compound-2 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
LIAROZOLE + Cyclophosphamide DC2PM3V Cyclophosphamide Adenocarcinoma (Cell Line: HT29) [3]
LIAROZOLE + Cyclophosphamide DC7BE2H Cyclophosphamide Melanoma (Cell Line: UACC-257) [3]
LIAROZOLE + Isoniazid DCY2ABY Isoniazid Adenocarcinoma (Cell Line: A549) [3]
LIAROZOLE + Nilotinib DC2MTBG Nilotinib Adenocarcinoma (Cell Line: HT29) [3]
LIAROZOLE + Nilotinib DCZZLC2 Nilotinib Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
LIAROZOLE + Nilotinib DCZIEYL Nilotinib Lung adenocarcinoma (Cell Line: HOP-62) [3]
LIAROZOLE + Nilotinib DCNYBMJ Nilotinib Lung adenocarcinoma (Cell Line: MDA-MB-231) [3]
LIAROZOLE + 10-hydroxycamptothecin DC5K6U4 10-hydroxycamptothecin Amelanotic melanoma (Cell Line: M14) [3]
LIAROZOLE + 10-hydroxycamptothecin DCZ2FHY 10-hydroxycamptothecin Large cell lung carcinoma (Cell Line: NCI-H460) [3]
LIAROZOLE + Topetecan DCUQNUV Topetecan Adenocarcinoma (Cell Line: DU-145) [3]
LIAROZOLE + Topetecan DCK4WF7 Topetecan Adenocarcinoma (Cell Line: HCT116) [3]
LIAROZOLE + Topetecan DC1MVPR Topetecan High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
LIAROZOLE + Topetecan DC2FOG9 Topetecan Large cell lung carcinoma (Cell Line: NCI-H460) [3]
LIAROZOLE + Terameprocol DCHAXX3 Terameprocol Amelanotic melanoma (Cell Line: M14) [3]
LIAROZOLE + SCH 727965 DCBXL1M SCH 727965 Adenocarcinoma (Cell Line: HT29) [3]
LIAROZOLE + SCH 727965 DC7KCFB SCH 727965 Lung adenocarcinoma (Cell Line: HOP-62) [3]
LIAROZOLE + Docetaxel DC2E5MW Docetaxel Adenocarcinoma (Cell Line: DU-145) [3]
LIAROZOLE + Docetaxel DC63M9X Docetaxel Adenocarcinoma (Cell Line: HT29) [3]
LIAROZOLE + Docetaxel DCK0AE8 Docetaxel Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
LIAROZOLE + Docetaxel DCVZKPZ Docetaxel High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
LIAROZOLE + Docetaxel DCXB1JR Docetaxel Lung adenocarcinoma (Cell Line: EKVX) [3]
LIAROZOLE + Docetaxel DCAK25Q Docetaxel Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
LIAROZOLE + Docetaxel DCBH0VD Docetaxel Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
LIAROZOLE + Raloxifene DCF9TTC Raloxifene Amelanotic melanoma (Cell Line: M14) [3]
LIAROZOLE + Raloxifene DC7YFSC Raloxifene High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
LIAROZOLE + Raloxifene DCAA9PP Raloxifene Malignant melanoma (Cell Line: UACC62) [3]
LIAROZOLE + Raloxifene DC8BII9 Raloxifene Melanoma (Cell Line: UACC-257) [3]
LIAROZOLE + Bendamustine hydrochloride DC6NY03 Bendamustine hydrochloride Adenocarcinoma (Cell Line: HT29) [3]
LIAROZOLE + Sirolimus DCR7DEB Sirolimus Lung adenocarcinoma (Cell Line: MDA-MB-231) [3]
LIAROZOLE + Mitomycin DCMGBDO Mitomycin Adenocarcinoma (Cell Line: HCT116) [3]
LIAROZOLE + Mitomycin DCBA0FE Mitomycin Adenocarcinoma (Cell Line: HCT-15) [3]
LIAROZOLE + SY-1425 DC1BW8G SY-1425 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
LIAROZOLE + Vincristine DCXT5I5 Vincristine Adenocarcinoma (Cell Line: HCT-15) [3]
LIAROZOLE + Vincristine DCMTIHE Vincristine Lung adenocarcinoma (Cell Line: EKVX) [3]
LIAROZOLE + Altretamine DCRC3U4 Altretamine Adenocarcinoma (Cell Line: OVCAR3) [3]
LIAROZOLE + Altretamine DCH7E4S Altretamine Adenocarcinoma (Cell Line: HCC-2998) [3]
LIAROZOLE + Altretamine DCNGN19 Altretamine Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
LIAROZOLE + TEM DCOU4E2 TEM Adenocarcinoma (Cell Line: HT29) [3]
LIAROZOLE + Idarubicin DCFIB9U Idarubicin Adenocarcinoma (Cell Line: OVCAR3) [3]
LIAROZOLE + Idarubicin DCCMVUS Idarubicin Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
LIAROZOLE + Bleomycin DCN915V Bleomycin Adenocarcinoma (Cell Line: HCT116) [3]
LIAROZOLE + Bortezomib DC689XT Bortezomib Adenocarcinoma (Cell Line: SW-620) [3]
LIAROZOLE + Bortezomib DCLFDPC Bortezomib Malignant melanoma (Cell Line: UACC62) [3]
LIAROZOLE + Cisplatin DCVQXR8 Cisplatin Melanoma (Cell Line: UACC-257) [3]
LIAROZOLE + ER819762 DC0YIIZ ER819762 Adenocarcinoma (Cell Line: DU-145) [3]
LIAROZOLE + ER819762 DC8RJG8 ER819762 Adenocarcinoma (Cell Line: A549) [3]
LIAROZOLE + ER819762 DCW55VB ER819762 Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
LIAROZOLE + ER819762 DC8Q9TT ER819762 Large cell lung carcinoma (Cell Line: NCI-H460) [3]
LIAROZOLE + Romidepsin DCFJFDS Romidepsin Large cell lung carcinoma (Cell Line: NCI-H460) [3]
LIAROZOLE + Romidepsin DC5EL4Y Romidepsin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
LIAROZOLE + Azacitidine DCRDRKB Azacitidine Adenocarcinoma (Cell Line: HT29) [3]
LIAROZOLE + Azacitidine DCJ936F Azacitidine Large cell lung carcinoma (Cell Line: NCI-H460) [3]
LIAROZOLE + Azacitidine DC54W9H Azacitidine Malignant melanoma (Cell Line: UACC62) [3]
LIAROZOLE + Pomalidomide DCQZ3BP Pomalidomide Adenocarcinoma (Cell Line: OVCAR3) [3]
LIAROZOLE + Vinflunine DC8JZ5R Vinflunine Adenocarcinoma (Cell Line: OVCAR3) [3]
LIAROZOLE + Vinflunine DCC10GK Vinflunine Adenocarcinoma (Cell Line: HCC-2998) [3]
LIAROZOLE + Mepacrine DCYXN6J Mepacrine Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
LIAROZOLE + Taxol DCOWBQL Taxol Large cell lung carcinoma (Cell Line: NCI-H460) [3]
LIAROZOLE + Taxol DCNT4R5 Taxol Malignant melanoma (Cell Line: UACC62) [3]
LIAROZOLE + Fludarabine DC3VYTU Fludarabine Adenocarcinoma (Cell Line: OVCAR3) [3]
LIAROZOLE + Fludarabine DCKNZGE Fludarabine Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
LIAROZOLE + PMID28870136-Compound-43 DC64HJF PMID28870136-Compound-43 Amelanotic melanoma (Cell Line: M14) [3]
LIAROZOLE + PMID28870136-Compound-43 DCGHP5Q PMID28870136-Compound-43 Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
LIAROZOLE + FORMESTANE DCBTJP5 FORMESTANE Adenocarcinoma (Cell Line: HCC-2998) [3]
LIAROZOLE + FORMESTANE DCZQYYP FORMESTANE Lung adenocarcinoma (Cell Line: EKVX) [3]
LIAROZOLE + Aminolevulinic Acid Hydrochloride DCDXOZI Aminolevulinic Acid Hydrochloride Amelanotic melanoma (Cell Line: M14) [3]
LIAROZOLE + Aminolevulinic Acid Hydrochloride DCVDZQ1 Aminolevulinic Acid Hydrochloride Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
LIAROZOLE + Estramustine DCXL8PH Estramustine Adenocarcinoma (Cell Line: OVCAR3) [3]
LIAROZOLE + Busulfan DC0NOCQ Busulfan Adenocarcinoma (Cell Line: OVCAR3) [3]
LIAROZOLE + Busulfan DCUXG01 Busulfan Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
LIAROZOLE + Dasatinib DC3Y3MT Dasatinib Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Mechlorethamine + LIAROZOLE DCJAH39 Mechlorethamine Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Mechlorethamine + LIAROZOLE DCG78Y9 Mechlorethamine Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Mechlorethamine + LIAROZOLE DCNGPLA Mechlorethamine Carcinoma (Cell Line: RXF 393) [4]
Mechlorethamine + LIAROZOLE DCUT1M5 Mechlorethamine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Methotrexate + LIAROZOLE DCPEZDF Methotrexate Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Pepstatin + LIAROZOLE DCQBWV7 Pepstatin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Picoplatin + LIAROZOLE DC17OXT Picoplatin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Picoplatin + LIAROZOLE DC2Y6NQ Picoplatin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Raloxifene + LIAROZOLE DCB3Q0B Raloxifene Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Raloxifene + LIAROZOLE DCIXN92 Raloxifene Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Raloxifene + LIAROZOLE DCIK2YJ Raloxifene Chronic myelogenous leukemia (Cell Line: K-562) [2]
Raloxifene + LIAROZOLE DCYFULL Raloxifene Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Ruxolitinib + LIAROZOLE DCKOVJY Ruxolitinib Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Thioguanine + LIAROZOLE DCXL3ML Thioguanine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Topotecan + LIAROZOLE DC16Q6Q Topotecan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Topotecan + LIAROZOLE DCHX2QY Topotecan Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Topotecan + LIAROZOLE DCKX3TO Topotecan Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Topotecan + LIAROZOLE DCNS9I4 Topotecan Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Topotecan + LIAROZOLE DCMP3Y4 Topotecan Glioma (Cell Line: SF-268) [3]
Topotecan + LIAROZOLE DC7ZSWT Topotecan Melanoma (Cell Line: MALME-3M) [3]
Topotecan + LIAROZOLE DC8BLS3 Topotecan Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Topotecan + LIAROZOLE DCGDFU2 Topotecan Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Topotecan + LIAROZOLE DCPC5NE Topotecan Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Topotecan + LIAROZOLE DCTV79K Topotecan Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Trifluridine + LIAROZOLE DC41ZAI Trifluridine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Trifluridine + LIAROZOLE DC8PSS5 Trifluridine Clear cell renal cell carcinoma (Cell Line: A498) [2]
Trifluridine + LIAROZOLE DCUP182 Trifluridine Glioma (Cell Line: SF-268) [2]
Trifluridine + LIAROZOLE DCLWDFF Trifluridine Adenocarcinoma (Cell Line: HT29) [3]
Trifluridine + LIAROZOLE DC51K0G Trifluridine Malignant melanoma (Cell Line: LOX IMVI) [3]
Trifluridine + LIAROZOLE DC2CKS0 Trifluridine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Uracil mustard + LIAROZOLE DCGPQSZ Uracil mustard Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Vandetanib + LIAROZOLE DCTE1T1 Vandetanib Invasive ductal carcinoma (Cell Line: BT-549) [4]
Vandetanib + LIAROZOLE DCQ01OU Vandetanib Astrocytoma (Cell Line: SNB-19) [3]
Vandetanib + LIAROZOLE DCHGR0Z Vandetanib Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Vemurafenib + LIAROZOLE DC43B0S Vemurafenib Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Vemurafenib + LIAROZOLE DC1ZJQR Vemurafenib Malignant melanoma (Cell Line: UACC62) [3]
Vemurafenib + LIAROZOLE DC32KIC Vemurafenib Malignant melanoma (Cell Line: LOX IMVI) [3]
Vemurafenib + LIAROZOLE DCPSUXA Vemurafenib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Vemurafenib + LIAROZOLE DCM6XQW Vemurafenib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Vismodegib + LIAROZOLE DC1O3PU Vismodegib Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Vismodegib + LIAROZOLE DCZK41B Vismodegib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Vismodegib + LIAROZOLE DCQF037 Vismodegib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
------------------------------------------------------------------------------------
⏷ Show the Full List of 311 DrugCom(s)

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5210).
2 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
3 Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.
4 Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.